Latest News
BNO NEWSLETTER JULY 2008 30-Jun-2008
OPEN BRIEFING - BNO & MERCK SERONO DEVELOPMENT AGREEMENT 24-Jun-2008
MERCK SERONO AND BIONOMICS ANNOUNCE MULTIPLE SCLEROSIS DEVELOPMENT AND LICENSING AGREEMENT 19-Jun-2008
BIONOMICS AWARDS GMP MANUFACTURE CONTRACT FOR ANXIETY DRUG CANDIDATE BNC210 16-Apr-2008
BIONOMICS PRESENTS BNC105 DATA AT INTERNATIONAL CANCER CONFERENCE 14-Apr-2008
BNO NEWSLETTER APRIL 2008 02-Apr-2008
BIONOMICS ADVANCES ANTI-ANXIETY CANDIDATE BNC210 11-Mar-2008
BIONOMICS STRENGTHENS BOARD WITH NEW APPOINTMENT 28-Feb-2008
CEO ON BNC105 PHASE I CLINICAL TRIALS 27-Feb-2008
TREATMENT OF FIRST PATIENT IN PHASE I CLINICAL TRIAL OF BIONOMICS’ ANTI-CANCER DRUG BNC105 26-Feb-2008
BIONOMICS ACHIEVES US$1 MILLION MILESTONE PAYMENT FROM GENMAB 19-Feb-2008
BIONOMICS NOW NEWSLETTER 21-Jan-2008
BIONOMICS’ ANTI-CANCER COMPOUND GAINS IND APPROVAL 22-Nov-2007
CHAIRMAN AND CEO ADDRESS 07-Nov-2007
BIONOMICS ACHIEVES KEY MILESTONES 07-Nov-2007
OPEN BRIEFING - CEO ON PIPELINE DEVELOPMENT STATUS 07-Nov-2007
AGM BROADCAST 07-Nov-2007
LATEST DATA PRESENTED AT INTERNATIONAL CONFERENCE 05-Oct-2007
NEWSLETTER TO SHAREHOLDERS 14-Sep-2007
2006 / 2007 FINANCIAL RESULTS – VARIATION TO 4E 07-Sep-2007
BIONOMICS' 2006/2007 PRELIMINARY FINAL RESULTS 29-Aug-2007
BIONOMICS TO DEVELOP CANCER DRUG TARGET BNO69 WITH SUPPORT FROM THE CANCER THERAPEUTICS CRC 06-Aug-2007
IBRO 2007 CONFERENCE POSTER - BNC210 13-Jul-2007
IBRO 2007 CONFERENCE POSTER - Kv1.3 ION CHANNEL BLOCKERS 13-Jul-2007
BIONOMICS PRESENTS MULTIPLE SCLEROSIS AND ANXIETY DRUG DATA AT INTERNATIONAL CONFERENCE 13-Jul-2007
S708A PLACEMENT NOTICE 05-Jul-2007
BNOOA OPTION EXPIRY NOTICE 03-Jul-2007
AUDIO BROADCAST - BIONOMICS RAISES $10 MILLION IN PRIVATE PLACEMENT 21-Jun-2007
BIONOMICS RAISES $10 MILLION IN PRIVATE PLACEMENT 20-Jun-2007
BIONOMICS NEWSLETTER - JUNE 2007 12-Jun-2007
BIONOMICS’ VALIDATES THIRD CANCER APPLICATION FOR ANTI-CANCER COMPOUND BNC105 04-Jun-2007
OPEN BRIEFING - BIONOMICS PIPELINE UPDATE 04-Jun-2007
AUDIO BROADCAST - BIONOMICS MD - NEW DRUG CANDIDATE FOR ANXIETY 31-May-2007
BIONOMICS VALIDATES DRUG CANDIDATE FOR ANXIETY 29-May-2007
BIONOMICS COMPLETES GMP SYNTHESIS OF CANCER DRUG BNC105 ON TIME AND ON BUDGET 23-Apr-2007
OPEN BRIEFING - UPDATE ON BNC105 MILESTONES 23-Apr-2007
US$890 MILLION VDA DEAL INDICATES VALUE OF BIONOMICS’ BNC105 CANCER COMPOUND 23-Apr-2007
BIONOMICS ESTABLISHES NEW LABORATORY FACILITY TO ACCELERATE LATER STAGE DRUG DEVELOPMENT 19-Apr-2007
BIONOMICS PRESENTS CANCER DATA AT AACR CONFERENCE 17-Apr-2007
AACR Poster 17-Apr-2007
INVESTOR BRIEFING - EXCELLENCE IN BIOTECHNOLOGY & INVESTMENT CONFERENCE, SYDNEY 20-Mar-2007
M & A PRESENTATION – EXCELLENCE IN BIOTECHNOLOGY & INVESTMENT CONFERENCE, SYDNEY 20-Mar-2007
BIONOMICS SHAREHOLDER NEWSLETTER – MARCH 2007 13-Mar-2007
BIONOMICS TAKES KEY STEP FORWARD IN THE DEVELOPMENT OF ANTI-CANCER DRUG BNC105 21-Feb-2007
BIONOMICS MEETS WITH FDA IN US 17-Jan-2007
BIONOMICS TO BENEFIT FROM AU$37.60M FEDERAL CRC GRANT FOR CANCER DRUG DEVELOPMENT 02-Jan-2007
BIONOMICS NEWSLETTER 04-Dec-2006
BIONOMICS MD UPDATES OUTLOOK 16-Nov-2006
BIONOMICS DELIVERS ON MILESTONES FOR DRUG DISCOVERY PROGRAMS 09-Nov-2006
AGM CHAIRMAN AND CEO ADDRESSES 2006 09-Nov-2006
BNO AUDIO BROADCAST 09-Nov-2006
BNO AUDIO BROADCAST 25-Oct-2006
BIONOMICS AND SAFC PHARMA SIGN CONTRACT TO MANUFACTURE BNC105 25-Oct-2006
ASIA PACIFIC LIFE SCIENCES FORUM - PRESENTATION 12-Oct-2006
